Gençer, Emine Begüm
Lor, Yuk Kit
Abomaray, Fawaz
El Andaloussi, Samir
Pernemalm, Maria
Sharma, Nidhi
Hagey, Daniel W
Görgens, André
Gustafsson, Manuela O
Le Blanc, Katarina
Asad Toonsi, Mawaddah
Walther-Jallow, Lilian
Götherström, Cecilia http://orcid.org/0000-0003-3782-0048
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 8 November 2023
Accepted: 23 February 2024
First Online: 13 March 2024
Declarations
:
: Ethics approval was obtained by the Regional Ethics Review Committee in Stockholm, Sweden. Fetal MSCs: “Studier av bindvävsceller i human fostervävnad.”, approval number 2006/308 − 31/2, date 2006-09-13 and 2013-05-18; Adult MSCs “Studier av bindvävsbildande celler i human benmärg, sk mesenkymala stamceller.”, approval number 446/00, date 2000-12-04. Oral and written consent was obtained from all donors.
: Not applicable.
: CG and LWJ are co-founders and co-owners of BOOST Pharma ApS. AG and SEA are consultants for and have equity interest in Evox Therapeutics. KLB is consultant for Swedish StromaBio AB. DWH, EBG, FA, MAT, MOG, MP, NS and YKL declare that they have no competing interests.